Co-expression of TWIST1 and ZEB2 in oral squamous cell carcinoma is associated with poor survival

Kong, Y.H. and Syed Zanaruddin, S.N. and Lau, S.H. and Ramanathan, A. and Kallarakkal, T.G. and Chong, V.K.V. and Wan Mustafa, W.M. and Abraham, M.T. and Rahman, Z.A.A. and Zain, R.B. and Cheong, S.C. (2015) Co-expression of TWIST1 and ZEB2 in oral squamous cell carcinoma is associated with poor survival. PLoS ONE. ISSN 1932-6203, DOI https://doi.org/10.1371/journal.pone.0134045.

Preview

PDF (Open Access) journal.pone.0134045.pdf - Published Version Download (1MB)

Abstract

Oral squamous cell carcinoma (OSCC) is an aggressive disease accounting for more than 260,000 cancer cases diagnosed and 128,000 deaths worldwide. A large majority of cancer deaths result from cancers that have metastasized beyond the primary tumor. The relationship between genetic changes and clinical outcome can reflect the biological events that promote cancer's aggressive behavior, and these can serve as molecular markers for improved patient management and survival. To this end, epithelial-mesenchymal transition (EMT) is a major process that promotes tumor invasion and metastasis, making EMT-related proteins attractive diagnostic biomarkers and therapeutic targets. In this study, we used immunohistochemistry to study the expression of a panel of transcription factors (TWIST1, SNAI1/2, ZEB1 and ZEB2) and other genes intimately related to EMT (CDH1 and LAMC2) at the invasive tumor front of OSCC tissues. The association between the expression of these proteins and clinico-pathological parameters were examined with Pearson Chi-square and correlation with survival was analyzed using Kaplan Meier analysis. Our results demonstrate that there was a significant differential expression of CDH1, LAMC2, SNAI1/2 and TWIST1 between OSCC and normal oral mucosa (NOM). Specifically, CDH1 loss was significantly associated with Broder's grading, while diffused LAMC2 was similarly associated with non-cohesive pattern of invasion. Notably, co-expression of TWIST1 and ZEB2 in OSCC was significantly associated with poorer overall survival, particularly in patients without detectable lymph node metastasis. This study demonstrates that EMT-related proteins are differentially expressed in OSCC and that the co-expression of TWIST1 and ZEB2 could be of clinical value in identifying patients with poor survival for appropriate patient management.

Item Type:	Article
Funders:	UNSPECIFIED
Subjects:	R Medicine > RK Dentistry
Divisions:	Faculty of Dentistry
Depositing User:	Mr Ahmad Azwan Azman
Date Deposited:	03 Nov 2015 00:47
Last Modified:	05 Jul 2017 01:35
URI:	http://eprints.um.edu.my/id/eprint/14375

Actions (login required)

View Item